Dindolyl Methane, or DIM as it is commonly referred to, is a very popular supplement for bodybuilders and other people who want to increase the growth of their muscles. Recent research has shown that DIM can pose health risks. DIM can cause liver damage when taken in excess. Kidney damage can also be a concern, and may lead to kidney failure. The potential long-term health risks of DIM make many athletes and bodybuilders ask the question: should I take a supplement with DIM?
The majority of people take diindolylmethane as a supplement to increase the production of testosterone. Testosterone is believed to function as an androgen, which means that it can cause hormonal changes in tissues. DIM has been shown in studies to mimic the effects of testosterone, as well as other hormones. Because men produce much more testosterone than women do Certain manufacturers have added diindolylmethane to their products in order to increase their competitiveness in male circles. The idea is that men will react to a product that replicates the effects of natural testosterone.
Many companies market DIM as a tumor suppressor. It’s true that diindolylmethane does reduce tumor growth in laboratory animals, however the animals were given the drug, not orally. To get the same effect in humans, diindolylmethane has to be consumed in high doses over a long period of time. Also, although the animals studied remained cancer-free for a number of years, they all developed liver disease at some point, likely because of the high levels of diindolylmethane circulating in their system. For a thorough understanding of the way DIM functions in the body, you should contact a medical practitioner.
The only way to demonstrate that DIM is effective in treating breast cancer is to conduct an experiment in which cells from healthy breast cells are exposed to high doses of diindolylmethane over a prolonged period of time. There are pros and negatives to using DIM just like any chemical. The advantages include the capability to mimic hormones. This lets you create insulin that inhibits the growth of cancer cells. Cons include the fact that diindolylmethane produces a damaging chemical called DMSO. Know more about what is diindolylmethane here.
One of the most common claims made about diindolylmethane’s use in an treatment for various ailments is that it is an natural, antibacterial, anti-cancer, and anti-fungal agent. The National Institute of Health, through an exhaustive review of supportive data, concluded that there was no evidence to support these claims. According to the Institute of Chemical Technology, there were no studies conducted to prove this claim. The Institute of Chemical Safety, conducting an in-depth study of the firestone’s safety profile concluded that the evidence provided by pharmaceutical companies regarding the benefits of diindolylmethane to humans were not completely reliable.
Van der Goes and. and. published their findings in a May 2021 issue of the Journal of Toxicology and Environmental Health. Van der Goes, et al., highlighted the potential dangers of diindolylmethane usage, which include allergic reactions and skin rashes asthma attacks as well as dizziness, headaches and respiratory issues. The daily dose recommended for this chemical, which is about one tenth to one teaspoon is 0.2 milligrams. It is unclear how much concentration it will have when this chemical is mixed with other substances. This substance is not safe because it has not been thoroughly tested.
The abstract of the view demonstrates that diindolylmethane’s use in cancer treatment is based on the idea that intracellular inhibition of pyruvate metabolism by flavenoids can be inhibited and prevents accumulation of oxalates and pyruvate metabolites in the renal tubule cells. However, the drug metabiplicate toxicology studies did not provide convincing evidence that the consumption of this chemical results in an overdose. In June 1996, the Food and Drug Administration approved this drug as a prescription drug. According to the FDA the company that manufactures firestone Tincture is currently conducting two major tests in Europe and the United States.
The abstract of the view also demonstrates the use of diindolylmethane in cancer treatment is based on the principle of inhibiting intracellular inhibition through flavenoids of pyruvate metabolism and thus preventing the accumulation of adenine and oxalates within the renal tubule cells. The drug metabiplicate toxicology studies have not proven that this chemical could cause overdose. The Food and Drug Administration approved the substance as a prescription drug in June 1996. According to the FDA, the manufacturer of firestone tincture is currently in the process of completing two major studies – one in Europe and another in the United States. According to FDA, the FDA states that the maker of the tincture is currently conducting two major studies in Europe and one in the United States.